title: Continuous administration of growth hormone does not prevent the decrease of IGF-I gene expression in zinc-deprived rats despite normalization of liver GH binding.
abstract: To determine the role of reduced liver GH binding (GHR) in the decreased IGF-I observed in zinc-deficient (ZD) animals, we investigated the effects of GHR restoration on growth, insulin-like growth factor I (IGF-I) and its binding proteins (IGFBPs) in ZD rats. Rats were fed for 4 weeks a zinc-deficient diet (ZD Zn, 0 ppm) or a Zinc-normal diet (pair-fed or PF; Zn, 75 ppm). ZD rats received continuous s.c. infusion of bovine growth hormone (bGH) (100 microg/d) for the 4 weeks or for the last week of the study. Compared with pair-fed rats, zinc deficiency produced attenuated weight gain (-43%, P < 0.001), lower serum IGF-I and liver IGF-I mRNA (-52%, P < 0.001 and -44%, P < 0.05), lower serum IGFBPs (IGFBP-3 -66%, IGFBP-4 -48%, 34-29 kDa IGFBP cluster -53%, P < 0.05), lower liver GHR and its mRNA (-20 and -34%, P < 0.05) and lower serum growth hormone binding protein (GHBP) and its mRNA (-56 and -48%, P < 0.05; all comparisons vs PF rats). Exogenous bGH given continuously normalized the liver GHR, serum GHBP and their liver mRNAs, as well as circulating IGFBPs. Despite restoration of GHR and GHBP to normal, growth, serum IGF-I and its liver mRNA were not stimulated by GH infusion in ZD rats, indicating that IGF-I synthesis requires the presence of zinc in addition to GH, and that the lack of growth-promoting action of GH in zinc-deprived rats results from a defect beyond GH binding to its liver receptors.
authors.affiliation: Diabetes and Nutrition Unit, University of Louvain School of Medicine, Brussels, Belgium.
authors.forename: N X
authors.initials: NX
authors.lastname: Ninh
authors.forename: D
authors.initials: D
authors.lastname: Maiter
authors.forename: P
authors.initials: P
authors.lastname: Lause
authors.forename: B
authors.initials: B
authors.lastname: Chrzanowska
authors.forename: L E
authors.initials: LE
authors.lastname: Underwood
authors.forename: J M
authors.initials: JM
authors.lastname: Ketelslegers
authors.forename: J P
authors.initials: JP
authors.lastname: Thissen
mesh_terms: D000818:Animals; D002352:Carrier Proteins / Q000235:genetics; D002417:Cattle; D005260:Female; D013006:Growth Hormone / Q000008:administration & dosage / Q000378:metabolism* / Q000494:pharmacology*; D007262:Infusions, Intravenous; D018969:Insulin-Like Growth Factor Binding Proteins / Q000097:blood; D007334:Insulin-Like Growth Factor I / Q000235:genetics*; D008099:Liver / Q000378:metabolism*; D012333:RNA, Messenger / Q000235:genetics; D051381:Rats; D017208:Rats, Wistar; D014158:Transcription, Genetic / Q000187:drug effects*; D015430:Weight Gain / Q000187:drug effects; D015032:Zinc / Q000172:deficiency* / Q000494:pharmacology
chemical_list: D002352:Carrier Proteins; D018969:Insulin-Like Growth Factor Binding Proteins; D012333:RNA, Messenger; D007334:Insulin-Like Growth Factor I; D013006:Growth Hormone; D015032:Zinc; C051815:somatotropin-binding protein